C60.9
Malignant neoplasm of penis, unspecified
Malignant neoplasm of the penis, unspecified, is a primary malignancy involving the tissues of the male external genitalia where the specific anatomical sub-site (such as the glans, body, or prepuce) is not documented or determined. Histologically, squamous cell carcinoma (SCC) is the predominant type, accounting for approximately 95% of penile cancers. Other less common types include melanoma, basal cell carcinoma, and sarcoma. Penile cancer is relatively rare in developed nations but exhibits higher incidence rates in regions with lower rates of neonatal circumcision and higher prevalence of Human Papillomavirus (HPV). The disease often progresses from a localized lesion to lymphatic spread, primarily targeting the inguinal lymph nodes. Early identification is crucial, as the prognosis is highly dependent on the stage of diagnosis and the presence of nodal involvement.
Clinical Symptoms
- Painless lump or ulcer on the penis
- Visible skin thickening or color changes on the penis
- Persistent discharge under the foreskin, sometimes malodorous
- Unexplained bleeding from the penis or under the foreskin
- Difficulty retracting the foreskin (acquired phimosis)
- Small, crusty bumps or reddish, velvety rashes
- Palpable swelling in the groin (inguinal lymphadenopathy)
- Pain (usually occurs in later stages or with secondary infection)
- Weight loss and fatigue (in advanced metastatic disease)
Common Causes
- Human Papillomavirus (HPV) infection, particularly high-risk strains like HPV 16 and 18
- Chronic inflammation of the penis (often associated with smegma accumulation)
- Phimosis (inability to retract the foreskin), which increases risk for chronic irritation
- History of cigarette smoking and tobacco use
- Advanced age (most commonly diagnosed in men over 60)
- Psoriasis treatment involving Psoralen and Ultraviolet A (PUVA) radiation
- Poor personal hygiene of the genital area
- Lichen sclerosus (balanitis xerotica obliterans), a chronic inflammatory skin condition
Documentation & Coding Tips
Transition from unspecified to site-specific codes by identifying the exact anatomical location involved, such as the prepuce, glans penis, or body of the penis.
Example: Patient presents with a 2.5 cm ulcerated mass involving the glans penis extending into the coronal sulcus. Biopsy confirms invasive squamous cell carcinoma. Documentation of glans involvement supports moving from C60.9 to C60.1. Chronic condition status: Active malignancy. Comorbidities: Type 2 diabetes mellitus with peripheral neuropathy.
Billing Focus: Identify the specific anatomical site of the neoplasm to avoid the C60.9 unspecified designation and ensure laterality is not required as the penis is a midline structure.
Document the histological type of the malignancy as this often dictates the treatment pathway and impacts medical necessity for specific procedures.
Example: Oncology note: 72-year-old male with biopsy-proven squamous cell carcinoma of the penis, site unspecified in pathology report. TNM staging is T2N1M0. Patient has a history of chronic phimosis. The documentation of TNM staging and squamous cell histology supports the severity of the malignancy for risk adjustment.
Billing Focus: Histology like squamous cell carcinoma vs. basal cell or melanoma provides clinical evidence for high-level E/M coding (99214/99215) and supports the use of chemotherapy administration codes.
Clearly document any lymph node involvement, particularly the inguinal and pelvic nodes, as this changes the clinical stage and the ICD-10 coding for secondary sites.
Example: Physical exam reveals palpable, fixed right-sided inguinal lymphadenopathy. Imaging shows a 3 cm primary penile mass (site unspecified) and enlarged inguinal nodes. Documentation includes C60.9 for the primary site and C77.4 for secondary malignant neoplasm of inguinal and lower limb lymph nodes. Patient is high risk due to nodal involvement.
Billing Focus: Coding for secondary sites like C77.4 alongside C60.9 justifies the medical necessity for lymph node dissections and radical surgical approaches.
Reference the presence or absence of Human Papillomavirus (HPV) as it is a significant prognostic indicator and may require additional ICD-10 codes for the infection.
Example: Patient has malignant neoplasm of the penis, unspecified, with p16 positivity on immunohistochemistry, indicating HPV-associated squamous cell carcinoma. Documentation includes code B97.7 to identify HPV as the cause of diseases classified elsewhere. Risk adjustment includes both the malignancy and the associated viral infection.
Billing Focus: Including B97.7 provides a complete clinical picture for diagnostic-related group (DRG) assignment in inpatient settings.
Specify the presence of associated conditions such as chronic phimosis or balanitis, which are frequently linked with penile malignancies.
Example: Patient with long-standing chronic phimosis presents with an unspecified malignant neoplasm of the penis. Physical exam shows restricted foreskin and underlying mass. Documenting N47.1 (Phimosis) alongside C60.9 demonstrates the underlying risk factors and complexity of the surgical approach.
Billing Focus: Documentation of complicating factors like phimosis supports higher surgical complexity and potentially the use of modifier 22 if the procedure is significantly more difficult.
Relevant CPT Codes
-
99204 - Office or other outpatient visit for the evaluation and management of a new patient, which requires a moderate level of medical decision making
Typically used for the initial specialist consultation where treatment options for the penile malignancy are discussed.
-
99214 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a moderate level of medical decision making
Standard code for follow-up visits during treatment or for monitoring disease progression.
-
54120 - Amputation of penis; partial
Common surgical treatment for localized penile neoplasms.
-
54130 - Amputation of penis, radical; with bilateral inguinal lymphadenectomy
Indicated for advanced stages of penile cancer with nodal involvement.
-
54100 - Biopsy of penis; cutaneous
Used to confirm the diagnosis of malignancy in suspicious lesions.
-
38760 - Inguinal lymphadenectomy, superficial, including Cloquet's node
Staging and therapeutic procedure for regional spread of penile cancer.
-
96413 - Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
Required for patients with advanced or metastatic penile cancer undergoing systemic therapy.
-
74177 - Computed tomography, abdomen and pelvis; with contrast material(s)
Standard imaging for staging to check for pelvic lymphadenopathy or distant metastasis.
-
54125 - Amputation of penis; complete
Surgical option for extensive primary tumors without clinical evidence of nodal spread.
-
99213 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a low level of medical decision making
Used for routine follow-up where the patient is stable and management is straightforward.
Related Diagnoses
- C60.0 - Malignant neoplasm of prepuce
- C60.1 - Malignant neoplasm of glans penis
- C60.2 - Malignant neoplasm of body of penis
- C77.4 - Secondary malignant neoplasm of inguinal and lower limb lymph nodes
- D07.4 - Carcinoma in situ of penis
- Z85.45 - Personal history of malignant neoplasm of penis
- B97.7 - Papillomavirus as the cause of diseases classified elsewhere
- N47.1 - Phimosis
- C79.89 - Secondary malignant neoplasm of other specified sites
- R39.81 - Functional urinary incontinence